Aktie 157744 TRANS GENIC INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Trans Genic Inc.

Aktien

157744

JP3635720000

2342

Verzögert Japan Exchange
Andere Börsenplätze
 07:31:20 26.04.2024 		% 5 Tage % 1. Jan.
248 JPY -5,70 % Intraday Chart für Trans Genic Inc. +10,22 % -4,62 %
2023 Trans Genic Inc. (TSE:2342) kündigt einen Aktienrückkauf für 300.000 Aktien an, was 1,78% für ¥100 Millionen entspricht. CI
2023 Trans Genic Inc. autorisiert einen Rückkaufplan. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Tranche Update on Trans Genic Inc.'s Equity Buyback Plan announced on November 22, 2023.
Trans Genic Inc.'s Equity Buyback announced on November 22, 2023, has closed with 300,000 shares, representing 1.78% for ¥78.62 million.
Tranche Update on Trans Genic Inc.'s Equity Buyback Plan announced on November 22, 2023.
Trans Genic Inc. announces an Equity Buyback for 300,000 shares, representing 1.78% for ¥100 million.
Trans Genic Inc. authorizes a Buyback Plan.
Trans Genic Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
Trans Genic Inc. acquired MASC Co., Ltd.
Eurofins Clinical Testing Lux Holding Sarl entered into a share purchase agreement to acquire GeneticLab Co., Ltd. from Trans Genic Inc. for ¥3.2 billion.
Tranche Update on Trans Genic Inc.'s Equity Buyback Plan announced on August 25, 2021.
Trans Genic Inc.'s Equity Buyback announced on August 25, 2021, has closed with 550,000 shares, representing 3.19% for ¥298.6 million.
Trans Genic Inc. completed the acquisition of Lunapas LLC.
Tranche Update on Trans Genic Inc.'s Equity Buyback Plan announced on August 25, 2021.
Trans Genic Inc. entered into share transfer agreement to acquire Lunapas LLC.
Trans Genic Inc. announces an Equity Buyback for 550,000 shares, representing 3.17% for ¥300 million.
Trans Genic Inc. authorizes a Buyback Plan.
Japan's Nikkei dips on investor caution, Topix buoyed by BOJ talk
Medicinal Chemistry Pharmaceuticals,Co.,Ltd. announced that it has received ¥0.08 million in funding from Trans Genic Inc.
Medicinal Chemistry Pharmaceuticals,Co.,Ltd. announced that it expects to receive ¥0.08 million in funding from Trans Genic Inc.
Trans Genic Inc. announced that it has received ¥17.45 million in funding from Merrill Lynch Japan Securities Co., Ltd., Investment Arm
Trans Genic Inc. announced that it expects to receive ¥17.45 million in funding from Merrill Lynch Japan Securities Co., Ltd., Investment Arm
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 157744 Aktie
  4. Nachrichten Trans Genic Inc.
  5. Andere Sprachen